AOS vs CNM

AOS exhibits mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score for distress risk assessment. Despite solid profitability metrics like a 28.21% ROE and 18.63% operating margin, the company faces headwinds from declining Q/Q EPS growth (-12.1%) and bearish insider activity. Valuation is stretched relative to Graham's defensive standard ($33.12) but aligns with growth-based intrinsic value ($106.35), while trading below analyst target ($78.27). The stock shows resilience in earnings beats over time, though recent deceleration and technical bearishness temper optimism.

CNM exhibits strong operational health with a Piotroski F-Score of 7/9, indicating robust financial stability and efficiency. However, the stock is currently trading at $49.50, which is slightly above its growth-based intrinsic value of $47.70 and significantly above its defensive Graham Number of $23.45. While earnings are growing (9.10% YoY), the company is facing a concerning trend of declining revenues (-6.90% YoY), suggesting a reliance on cost-cutting rather than organic expansion. Technical trends and insider sentiment are currently bearish, offsetting the optimistic analyst target of $60.88.